BioVentures, Incorporated

BIOMARKER

diagnostic reagents for clinical medical laboratory use in testing DNA and a kit composed primarily of said diagnostic reagents;bio-marker;

BIOTRACKER

bio-tracker;chemicals; namely, buffers for use in testing DNA;

DECISION FACTOR

quality control diagnostic reagents for scientific or research use in the analysis of nucleic acids;

DETECT. DISCOVER. IDENTIFY.

DETECT DISCOVER IDENTIFY;Reagents for use in genetic, medical and scientific analysis and research, namely analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, haplotyes and heterozygosity and for use in identifying diseases; assays and kits comprised primarily of reagents, with or without reagent carriers, for use in genetic, medical and scientific analysis and research for analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, haplotyes and heterozygosity and for use in identifying diseases;[Chemical analysis of biochemicals; services for analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, haplotyes and heterozygosity; and services identifying diseases];

DETECT. DISCOVER. IDENTIFY.

COMPUTER SOFTWARE FOR ANALYZING, DETECTING, QUANTIFYING AND SEQUENCING POLYPEPTIDES AND POLYNUCLEOTIDES, INCLUDING POLYPEPTIDE VARIANTS, POLYNUCLEOTIDE VARIANTS, GENETIC MUTATIONS, SINGLE NUCLEOTIDE POLYMORPHISMS, HAPLOTYES AND HETEROZYGOSITY FOR USE IN GENETIC, MEDICAL AND SCIENTIFIC ANALYSIS AND RESEARCH, AND FOR USE IN IDENTIFYING DISEASES;RESEARCH AND DEVELOPMENT OF NEW PRODUCTS FOR OTHERS IN THE NATURE OF DESIGNING BIOLOGICAL MOLECULES, INCLUDING POLYNUCLEOTIDES, POLYPEPTIDES AND VECTORS; CHEMICAL ANALYSIS SERVICES IN THE NATURE OF EVALUATING BIOLOGICAL MOLECULES, INCLUDING POLYNUCLEOTIDES, POLYPEPTIDES AND VECTORS; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS FOR OTHERS, NAMELY, SERVICES PRODUCING BIOLOGICAL MOLECULES, INCLUDING POLYNUCLEOTIDES, POLYPEPTIDES AND VECTORS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES FOR OTHERS; CHEMICAL ANALYSIS AND SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF DRUG DEVELOPMENT, NAMELY EVALUATING THE ACTIVITY OF DRUGS AND CANDIDATE SUBSTANCES FOR DRUGS FOR OTHERS;

NAVIGATING GENETIC DIVERSITY

In the statement, Column 1, line 5, GENERIC should be deleted, and, GENETIC should be inserted. Column 1, line 12, HAPLOTYES should be deleted, and, HAPLOTYPES should be inserted., Column 1, line 16, RESEARCH should be deleted, and, REAGENT should be inserted. Column 2, line 1, HAPLOTYES should be deleted, and, HAPLOTYPES should be inserted. Column 2, line 11, HAPLOTYES should be deleted, and, HAPLOTYPES should be inserted.;Reagents for use in [ generic ] * GENETIC *, medical and scientific analysis and research, namely analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms,[ haplotyes ] * HAPLOTYPES * and heterozygosity and for use in identifying diseases; assays and kits comprised primarily of reagents, with or without [ research ] * REAGENT * carriers, for use in genetic, medical and scientific analysis and research for analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides,including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, [ haplotyes ] * HAPLOTYPES * and heterozygosity and for use in identifying diseases;[Chemical analysis of biochemicals; services for analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, [ haplotyes ] * HAPLOTYPES * and heterozygosity; and services identifying diseases];

NAVIGATING GENETIC DIVERSITY

In the heading delete class 9. In the statement, Column 1, line 5 through 16, should be deleted.;research and development of new products for others in the nature of designing biological molecules, including polynucleotides, polypeptides and vectors; chemical analysis services in the nature of evaluating biological molecules, including polynucleotides, polypeptides and vectors; research and development of new products for others, namely, services producing biological molecules, including polynucleotides, polypeptides and vectors; pharmaceutical drug development services for others; chemical analysis and scientific research services in the field of drug development, namely evaluating the activity of drugs and candidate substances for drugs for others;

NAVIGATING THE UNIVERSE OF GENETIC DIVERSITY

REAGENTS FOR USE IN GENETIC, MEDICAL AND SCIENTIFIC ANALYSIS AND RESEARCH, NAMELY ANALYZING, DETECTING, QUANTIFYING AND SEQUENCING POLYPEPTIDES AND POLYNUCLEOTIDES, INCLUDING POLYPEPTIDE VARIANTS, POLYNUCLEOTIDE VARIANTS, GENETIC MUTATIONS, SINGLE NUCLEOTIDE POLYMORPHISMS, HAPLOTYES AND HETEROZYGOSITY AND FOR USE IN IDENTIFYING DISEASES ASSAYS AND KITS COMPRISED PRIMARILY OF REAGENTS, WITH OR WITHOUT REAGENT CARRIERS, FOR USE IN GENETIC, MEDICAL AND SCIENTIFIC ANALYSIS AND RESEARCH FOR ANALYZING, DETECTING, QUANTIFYING AND SEQUENCING POLYPEPTIDES AND POLYNUCLEOTIDES, INCLUDING POLYPEPTIDE VARIANTS, POLYNUCLEOTIDE VARIANTS, GENETIC MUTATIONS, SINGLE NUCLEOTIDE POLYMORPHISMS, HAPLOTYES AND HETEROZYGOSITY AND FOR USE IN IDENTIFYING DISEASES;CHEMICAL ANALYSIS OF BIOCHEMICALS; SERVICES FOR ANALYZING, DETECTING, QUANTIFYING AND SEQUENCING POLYPEPTIDES AND POLYNUCLEOTIDES, INCLUDING POLYPEPTIDE VARIANTS, POLYNUCLEOTIDE VARIANTS, POLYNUCLEOTIDES VARIANTS, GENETIC MUTATIONS, SINGLE NUCLEOTIDE POLYMORPHISMS, HAPLOTYES AND HETEROZYGOSITY; AND SERVICES IDENTIFYING DISEASES;

NAVIGATING THE UNIVERSE OF GENETIC DIVERSITY

research and development of new products for others in the nature of designing biological molecules, including polynucleotides, polypeptides and vectors; chemical analysis services in the nature of evaluating biological molecules, including polynucleotides, polypeptides and vectors; research and development of new products for others, namely, services producing biological molecules, including polynucleotides, polypeptides and vectors; pharmaceutical drug development services for others; chemical analysis and scientific research services in the field of drug development, namely evaluating the activity of drugs and candidate substances for drugs for others;